Hikma Pharmaceuticals PLC Annual report 2010 remunerAtion Committee rePort Continued Directors share options The aggregate emoluments disclosed above do not include any amounts or the value of options to acquire Ordinary Shares of the Company granted or held by the Executive Directors.
On 4 November 2010, the Chief Executive Officer, Said Darwazah exercised a nil-cost option over 100,000 Ordinary Shares in the Company granted under the 2005 Long Term Incentive Plan, retaining all of the shares so exercised.
The share price at the point of exercise was 7.77p, theexchange rate was $1.61:1 and, therefore, the value of this holding at that point was approximately $1,249,000.
No other options were exercised by directors during the year and no options expired unexercised.
Furthermore, there were no variations to the terms and conditions of share options during the year.
Hikma Pharmaceuticals PLC 2004 Stock Option Plan None of the Directors had any share options outstanding under this scheme at the beginning of or during the year under review and no further options will be granted under this plan.
Options granted under the 2004 Plan are not subject to performance criteria, though vesting of options under the 2004 Plan was conditional on the successful listing of the Companys shares on the London Stock Exchange.
Hikma Pharmaceuticals PLC 2005 Long Term Incentive Plan LTIP In respect of each of the Executive Directors, the aggregate number of shares under option outstanding at the year-end was: number of LtiP shares As at As at 31 december 31 december director 2010 2009 said darwazah 320,000 315,000 mazen darwazah 249,000 179,000 The aggregate options detailed above relate to the following unexercised options over Ordinary Shares as at 31 December 2010: number of Price paid initial date director LtiP shares for award exercise price date of award of vesting date of expiry said darwazah 90,000 nil 29 April 29 April 29 April 2008 2011 2018 125,000 nil 19 may 19 may 19 may 2009 2012 2019 105,000 nil 2 november 2 november 2 november 2010 2013 2020 mazen darwazah 50,000 nil 10 september 10 september 10 september 2007 2010 2017 54,000 nil 29 April 29 April 29 April 2008 2011 2018 75,000 nil 19 may 19 may 19 may 2009 2012 2019 70,000 nil 2 november 2 november 2 november 2010 2013 2020 The closing market price for the Ordinary Shares on 31 December 2010 was 811.5 pence.
During the period from 1 January 2010 to the year end the closing price for the Companys shares ranged from a low of 514.0 pence to a high of 829.5 pence.
Audit The emoluments and Directors interests information disclosed in the Directors report on remuneration, which is required by Schedule 8 of the Regulations and the Companies Act 2006 as amended, has been audited.
Approved by the Board of Directors on 15 March 2011 and signed on its behalf by michael Ashton Chairman of the Remuneration Committee 68
